Sorry, this entry is only available in Français.
A press review is only a summary of media analysis and press articles that have been read to realize it each day. The press review can not be interpreted as reflecting the point of view of Inserm. The link towards the original article, when existing, is indicated in the synthesis.
These links, active at the updating date, may become unavailable in the following days. This depends on the media policy.
Launch of a European clinical trial against COVID-19
New Antibiotics Developed by Inserm and Université de Rennes 1
The BCG vaccine against COVID-19 – really?
A novel, more effective method for diagnosing Alzheimer’s disease